The Valley Desk

NCT00678886 · Interventional trial

Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

Overall registry status Completed

Phase 3

Conditions Diabetes Mellitus, Type 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov